Surgical treatment for intrahepatic cholangiocarcinoma

被引：20
作者：
Uenishi T. [1 ]
Yamamoto T. [1 ]
Takemura S. [2 ]
Kubo S. [2 ]
机构：
[1] Department of Surgery, Ishikiri-Seiki Hospital, Higashi-osaka, Osaka 579-8026
[2] Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka
来源：
Clinical Journal of Gastroenterology | 2014年 / 7卷 / 2期
关键词：
Adjuvant chemotherapy; Intrahepatic cholangiocarcinoma; Surgical treatment;
D O I：
10.1007/s12328-014-0460-z
中图分类号：
学科分类号：
摘要：
Despite surgical treatment for intrahepatic cholangiocarcinoma (ICC) becoming more widely available, the prognosis after hepatic resection for ICC remains poor. Because ICC is relatively rare, the TNM staging system for ICC was finally established in the 2000s. Resection margin status and lymph node metastases are important prognostic factors after surgery for ICC; however, the true impact of wide resection margins or lymph node dissection on postoperative survival is unclear. Although adjuvant chemotherapy can improve the postoperative prognosis of patients with various types of cancer, no standard regimen has been developed for ICC. Over 50 % of patients suffer postoperative recurrence, even after curative resection, and no effective treatment for recurrent ICC has been established. Therefore, despite advances in imaging studies and hepatobiliary surgery, significant challenges remain in improving the prognosis of patients with ICC. © 2014 Springer.
引用
收藏
页码：87 / 93
页数：6
相关论文
共 72 条
[1]  
Ikai I., Arii S., Okazaki M., Okita K., Omata M., Kojiro M., Takayasu K., Nakanuma Y., Makuuchi M., Matsuyama Y., Monden M., Kudo M., Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan, Hepatology Research, 37, 9, pp. 676-691, (2007)
[2]  
Khan S.A., Thomas H.C., Davidson B.R., Taylor-Robinson S.D., Cholangiocarcinoma, Lancet, 366, 9493, pp. 1303-1314, (2005)
[3]  
Okuda K., Nakanuma Y., Miyazaki M., Cholangiocarcinoma: Recent progress. Part 1: Epidemiology and etiology, Journal of Gastroenterology and Hepatology, 17, 10, pp. 1049-1055, (2002)
[4]  
Khan S.A., Taylor-Robinson S.D., Toledano M.B., Beck A., Elliott P., Thomas H.C., Changing international trends in mortality rates for liver, biliary and pancreatic tumours, Journal of Hepatology, 37, 6, pp. 806-813, (2002)
[5]  
Lieser M.J., Barry M.K., Rowland C., Ilstrup D.M., Nagorney D.M., Surgical management of intrahepatic cholangiocarcinoma: A 31-year experience, Journal of Hepato-Biliary-Pancreatic Surgery, 5, 1, pp. 41-47, (1998)
[6]  
Nathan H., Pawlik T.M., Wolfgang C.L., Choti M.A., Cameron J.L., Schulick R.D., Trends in survival after surgery for cholangiocarcinoma: A 30-year population-based SEER database analysis, J Gastrointest Surg, 11, pp. 1488-1496, (2007)
[7]  
Uenishi T., Kubo S., Yamazaki O., Yamada T., Sasaki Y., Nagano H., Et al., Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases, J Hepatobiliary Pancreat Surg, 15, pp. 417-422, (2008)
[8]  
Okabayashi T., Yamamoto J., Kosuge T., Shimada K., Yamasaki S., Takayama T., Makuuchi M., A new staging system for mass-forming intrahepatic cholangiocarcinoma: Analysis of preoperative and postoperative variables, Cancer, 92, 9, pp. 2374-2383, (2001)
[9]  
Choi S.B., Kim K.S., Choi J.Y., Park S.W., Choi J.S., Lee W.J., Et al., The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: Association of lymph node metastasis and lymph node dissection with survival, Ann Surg Oncol, 16, pp. 3048-3056, (2009)
[10]  
Ribero D., Pinna A.D., Guglielmi A., Ponti A., Nuzzo G., Giulini S.M., Et al., Surgical approach for long-term survival of patients with intrahepatic cholangiocarcinoma: A multi-institutional analysis of 434 patients, Arch Surg, 147, pp. 1107-1113, (2012)
12345678